Raymond James Financial »

Bicara Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 68k 15.79
2025-06-30 $629k 68k 9.29

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
Blackstone Group
Millennium Management
Geode Capital Management
Fil
Acorn Capital Advisors

View all funds holding Bicara Therapeutics